A detailed history of Alberta Investment Management Corp transactions in Repligen Corp stock. As of the latest transaction made, Alberta Investment Management Corp holds 63,233 shares of RGEN stock, worth $10.5 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
63,233
Previous 63,233 -0.0%
Holding current value
$10.5 Million
Previous $7.97 Million 18.05%
% of portfolio
0.09%
Previous 0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$120.0 - $182.95 $132,000 - $201,245
-1,100 Reduced 1.71%
63,233 $7.97 Million
Q1 2023

May 15, 2023

BUY
$154.26 - $198.1 $169,686 - $217,910
1,100 Added 1.74%
64,333 $10.8 Million
Q4 2022

Feb 14, 2023

BUY
$162.42 - $220.56 $1.13 Million - $1.53 Million
6,959 Added 12.37%
63,233 $10.7 Million
Q3 2022

Nov 14, 2022

BUY
$160.42 - $256.21 $9.03 Million - $14.4 Million
56,274 New
56,274 $10.5 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $9.21B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Alberta Investment Management Corp Portfolio

Follow Alberta Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alberta Investment Management Corp with notifications on news.